The French state agency, Oseo Innovation, has awarded €1.8 million to a privately-held molecular diagnostics company in Nantes to support a biomarker project aimed at predicting rejections of kidney transplants. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals
